NuWays reiterates BUY on Eckert & Ziegler, sets EUR 21.50 price target
NuWays reiterated a BUY rating on Eckert & Ziegler, setting a 12-month target price of EUR 21.50. Report flags a valuation gap versus recent radiopharma M&A, citing implied multiples of 5.3x sales and 16x manufacturing EBITDA for ITM. NuWays argues consolidation increases demand for independent isotope supply, position